COST BENEFIT ANALYSIS OF INTRAVENOUS (IV) TO ORAL (PO) SWITCH OF PARACETAMOL IN A TERTIARY CARE HOSPITAL
Senior Clinical Pharmacist, Dept. of pharmacy, Shaukat Khanum Memorial Cancer Hospital & Research Center
Associate Director Pharmaceutical & Ambulatory Care Services, Dept. of pharmacy, Shaukat Khanum Memorial Cancer Hospital & Research Center. Resident Pharmacist, Dept. of pharmacy, Shaukat Khanum Memorial Cancer Hospital & Research Center. Staff Pharmacist, Dept. of pharmacy, Shaukat Khanum Memorial Cancer Hospital & Research Center
Keywords: Intravenous, Oral, Paracetamol
Background: Intravenous to oral switch of medication in clinically stable patients is a part of appropriate medication reconciliation process, which ensures lower cost and reduced hospital stay. Paracetamol injection use has been very frequent in hospital setting especially during emergency care.At Shaukat Khanum Memorial Cancer Hospital 7 Research Center (SKMCH&RC), an online restriction for paracetamol injection prescribing was introduced in Jun, 2014 to ensure parenteral use only in indicated cases.
Aim: In this retrospective study, it was intended to evaluate the impact of online IV paracetamol restriction on consumption of parenteral paracetamol in the institute.
Method:It was a retrospective cross-sectional study. Paracetamol injection consumption was observed for the year 2014 month-wise using hospital information system (HIS).
Results:The number of paracetamol injections used before implementation of restriction was 11429 from Jan to Jun, 2014. After implementation of restriction, the number was reduced to 8219 in total from Jun, 2014 to Dec, 2014. There was a 28.1% decrease in the use of paracetamol injectable dosage form after implementation of the restriction. Rs. 321,000/- approx. were saved as a result of reduced consumption.
Conclusion: Restriction of intravenous paracetamol prescribing is associated with reduced parenteral paracetamol prescribing and lower cost of therapy.
© 2016 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits